To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Linda Fogelstrand - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Linda Fogelstrand

Universitetslektor, adjungerad

Linda Fogelstrand
Universitetslektor, adjungerad
linda.fogelstrand@clinchem.gu.se
+46 31-342 9296

Postal Address: Box 100, 40530 Göteborg
Visiting Address: Gula stråket 8 , 41345 Göteborg


Department of Laboratory Medicine at Institute of Biomedicine (More Information)
Sahlgrenska universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 8 , 413 45 Göteborg

Latest publications

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia
K. L. Juul-Dam, H. B. Ommen, C. G. Nyvold, C. Walter, H. Vålerhaugen et al.
British Journal of Haematology, Journal article 2020
Journal article

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Edith Schneider, Nicole Pochert, Christoph Ruess, Liam MacPhee, Leo Escano et al.
Leukemia, Journal article 2020
Journal article

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
S Modvig, H O Madsen, S M Siitonen, S Rosthøj, A Tierens et al.
Leukemia, Journal article 2019
Journal article

Serial Minimal Residual Disease Assessment by qPCR in Peripheral Blood is an Informative Disease Surveillance Tool in Childhood Acute Myeloid Leukaemia
HB Ommen, C Nyvold, C Walter, H Valerhaugen, V Kairisto et al.
NOPHO 36th Annual meeting 2018 1 - 5 June, Vilnius, Lithuania, Conference contribution 2018
Conference contribution

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia
KL Juul-Dam, HB Ommen, C Guldborg Nyvold, C Walter, H Vålerhaugen et al.
Blood. 132 (Supplement 1): 2754., Conference paper 2018
Conference paper

Showing 1 - 10 of 47

2020

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia
K. L. Juul-Dam, H. B. Ommen, C. G. Nyvold, C. Walter, H. Vålerhaugen et al.
British Journal of Haematology, Journal article 2020
Journal article

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Edith Schneider, Nicole Pochert, Christoph Ruess, Liam MacPhee, Leo Escano et al.
Leukemia, Journal article 2020
Journal article

2019

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
S Modvig, H O Madsen, S M Siitonen, S Rosthøj, A Tierens et al.
Leukemia, Journal article 2019
Journal article

2018

Serial Minimal Residual Disease Assessment by qPCR in Peripheral Blood is an Informative Disease Surveillance Tool in Childhood Acute Myeloid Leukaemia
HB Ommen, C Nyvold, C Walter, H Valerhaugen, V Kairisto et al.
NOPHO 36th Annual meeting 2018 1 - 5 June, Vilnius, Lithuania, Conference contribution 2018
Conference contribution

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia
KL Juul-Dam, HB Ommen, C Guldborg Nyvold, C Walter, H Vålerhaugen et al.
Blood. 132 (Supplement 1): 2754., Conference paper 2018
Conference paper

Showing 1 - 10 of 47

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?